EP003 — The Power Curve

The biggest story in medicine right now, told as a curve. Why did weight-loss results jump from 8% to nearly 30% in just a few years? We trace the line from the first GLP-1 drugs to the triple-agonist sitting at the top — retatrutide — and everything the community is doing with these compounds that the pharmacy counter never sees. Plus the venom origin myth everyone repeats.

Link To Services

In this episode

One clean idea organizes the whole episode: stack more gut-hormone targets, and the results climb. We follow that curve from approved drugs to the research frontier.
•Where GLP-1 came from — the discovery story, and the Gila-monster-venom origin tale (we check whether it’s actually true).
•The power curve itself: single, double, and triple agonists — and the counterintuitive reason that adding a hormone which raises blood sugar makes the strongest fat-loss drug ever built.
•Retatrutide, the unapproved apex: the promises, the rumors, and the honest “we don’t know yet.”
•The known quantities — semaglutide and tirzepatide — and the deep pipeline lining up behind them.
•Effects beyond the scale: metabolic, liver, sleep, and the muscle-loss question.
•The community’s research-grade corner — AOD-9604, tesofensine, MOTS-c and friends.
The most-hyped category on the show, kept honest about what’s approved and what’s still an experiment.

Everything discussed on this show is for informational and educational purposes only, based on published research and community-reported experience. We are not doctors, and nothing here constitutes medical advice. Our goal is simple: to give you enough information to have a real, informed conversation with your own physician — one where you walk in knowing the right questions to ask. Please involve a qualified healthcare provider before making any changes to your health protocols. Don’t skip that step.